Global Female Stress Urinary Incontinence Treatment Devices Industry Set to Flourish at a 6.2% CAGR, Surpassing US$ 1.07 Billion by 2029 | FMI

The Global Female Stress Urinary Incontinence Treatment Devices Industry currently stands at a valuation of US$ 702.4 Million and is poised for substantial growth, with a projected Compound Annual Growth Rate (CAGR) of 6.2% from 2022 to 2029. Anticipated to culminate in a market worth US$ 1.07 Billion by the conclusion of 2029, this expansion signifies significant industry advancement.

A few medical conditions such as enlarged prostate, muscle damage, excess urine formation, multiple sclerosis, Parkinson’s disease, spinal cord injury, and loss of storage capacity in the rectum are also expected to boost the incidence of stress urinary incontinence among women, which is fuelling the demand for female stress urinary incontinence treatment devices.

The practice of using female stress urinary incontinence treatment devices has changed dramatically over the past decade. The number of procedures undertaken appears to be increasing, and the shift in relative numbers of different procedures has been remarkable. For instance, in England, the annual number of operations undertaken using female stress urinary incontinence treatment devices between 1997-1998 and 2005-2006 increased by 28%, despite a reduction of over 90% in the number of colposuspension and needle suspension procedures.

Request a Sample of this Report Now!
https://www.futuremarketinsights.com/reports/sample/rep-gb-2533

Healthy Revenue Growth Projected Through 2029

According to the latest research by FMI, the Global Female Stress Urinary Incontinence Treatment Devices Industry is estimated to have accounted for ~ US$ 560 Mn in terms of value in 2018. The report on the female stress urinary incontinence treatment devices market further projects that the Global Female Stress Urinary Incontinence Treatment Devices Industry is likely to grow at a CAGR of ~ 6% during the period 2019-2029.

However, due to the presence of a wide range of products in the Global Female Stress Urinary Incontinence Treatment Devices Industry , small players are gaining interest and are selling their products at a lower price. An increase in the penetration of private-label brands at much lower prices is expected to decrease the average overall price of female stress urinary incontinence treatment devices. This is likely to restrain the growth of the Global Female Stress Urinary Incontinence Treatment Devices Industry, as it is likely to hamper the demand for expensive products.

Rapid changes have taken place in developing countries over the past few years. The improper implementation of regulatory guidelines and the lack of proper healthcare infrastructure in developing regions, such as the Middle East & Africa, and Latin America, are among the factors that are expected to restrain the growth of the Global Female Stress Urinary Incontinence Treatment Devices Industry.

50% Revenue Shares Accounted by North America

The female stress urinary incontinence treatment devices market has been analyzed across the regions of North America, Latin America, Europe, East Asia, South Asia, Oceania, and the Middle East & Africa. North America, followed by Europe, is a prominent region in the Global Female Stress Urinary Incontinence Treatment Devices Industry . North America accounted for a revenue share of about 50% in 2018 in the female stress urinary incontinence treatment devices market. Europe also accounted for a prominent revenue share and is followed by East Asia in the female stress urinary incontinence treatment devices market.

Click Here to Request Methodology!
https://www.futuremarketinsights.com/request-report-methodology/rep-gb-2533

The Global Female Stress Urinary Incontinence Treatment Devices Industry report tracks some of the key companies operating in female stress urinary incontinence treatment devices market, such as Boston Scientific Corporation, BD, Coloplast Corporation, Caldera Medical, and Ethicon US LLC (Johnson & Johnson Services, Inc.). The majority of the key regional players in the Global Female Stress Urinary Incontinence Treatment Devices Industry are highly focused on expanding their product connectivity and reach with the help of domestic distributors of female stress urinary incontinence treatment devices. Moreover, the manufacturers of female stress urinary incontinence treatment devices are focused on strengthening their businesses in high-growth markets, such as India, Japan, and China, by expanding their distribution and sales channels.

Key Segments Of Female Stress Urinary Incontinence Treatment Devices Industry Survey Global Female Stress Urinary Incontinence Treatment Devices Industry by Product Type:

• Sling Systems
  • Mid-Urethral Slings
  • Sub-Urethral Slings
• Pessaries
• Artificial Urinary Sphincters (AUS)
• Injectable Urethral Bulking Agents

Global Female Stress Urinary Incontinence Treatment Devices Industry by End Use:

• Female Stress Urinary Incontinence Treatment Devices for Hospitals
• Female Stress Urinary Incontinence Treatment Devices for Gynaecological Clinics
• Female Stress Urinary Incontinence Treatment Devices for Homecare Settings

Click Here To Buy Your Full Report
https://www.futuremarketinsights.com/checkout/2533

Global Female Stress Urinary Incontinence Treatment Devices Industry by Region:

• North America Female Stress Urinary Incontinence Treatment Devices Market
• Latin America Female Stress Urinary Incontinence Treatment Devices Market
• Europe Female Stress Urinary Incontinence Treatment Devices Market
• East Asia Female Stress Urinary Incontinence Treatment Devices Market
• South Asia & Pacific Female Stress Urinary Incontinence Treatment Devices Market
• Middle East & Africa (MEA) Female Stress Urinary Incontinence Treatment Devices Market

Author

Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.

Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 5,000 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:      

Nandini Singh Sawlani

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube